Skip to main content
Livermore
Livermore
ZHEN

Harding Loevner LP

SEC CIK
0000928196
Latest filing
Aug 14, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Harding Loevner LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,163
Value
$577.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Harding Loevner LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,163$577.7K<0.1%−312,383−99.6%ReducedHolders
Q1 2026313,546$140.0M1.4%−78,319−20.0%ReducedHolders
Q4 2025391,865$177.7M1.6%−64,123−14.1%ReducedHolders
Q3 2025455,988$178.6M1.3%−255,623−35.9%ReducedHolders
Q2 2025711,611$316.8M2.1%+13,152+1.9%AddedHolders
Q1 2025698,459$338.6M2.6%−125,168−15.2%ReducedHolders
Q4 2024823,627$331.7M2.2%−328,998−28.5%ReducedHolders
Q3 20241,152,625$536.1M3.1%−31,783−2.7%ReducedHolders
Q2 20241,184,408$555.2M3.1%−38,630−3.2%ReducedHolders
Q1 20241,223,038$511.2M3.2%−98,191−7.4%ReducedHolders
Q4 20231,321,229$538.6M3.0%−25,522−1.9%ReducedHolders
Q3 20231,346,751$468.3M3.1%−191,519−12.5%ReducedHolders
Q2 20231,538,270$541.3M3.2%−288,354−15.8%ReducedHolders
Q1 20231,826,624$575.5M3.3%−13,897−0.8%ReducedHolders
Q4 20221,840,521$531.5M3.1%+200,704+12.2%AddedHolders
Q3 20221,639,817$474.8M3.1%−93,874−5.4%ReducedHolders
Q2 20221,733,691$488.5M3.0%−35,585−2.0%ReducedHolders
Q1 20221,769,276$417.3M2.3%−112,595−6.0%ReducedHolders
Q4 20211,881,871$413.3M1.6%−29,232−1.5%ReducedHolders
Q3 20211,911,103$346.7M1.4%−87,975−4.4%ReducedHolders
Q2 20211,999,078$403.1M1.5%+15,989+0.8%AddedHolders
Q1 20211,983,089$426.1M1.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.